HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 281 filers reported holding HAEMONETICS CORP in Q4 2018. The put-call ratio across all filers is 2.89 and the average weighting 0.1%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Black Creek Investment Management Inc. | 1,014,941 | $33,077,000 | 3.62% |
| Camber Capital Management LP | 1,202,000 | $39,173,000 | 3.07% |
| AMERICAN CAPITAL MANAGEMENT INC | 718,380 | $23,412,000 | 2.76% |
| Van Berkom & Associates Inc. | 1,258,322 | $41,009,000 | 2.31% |
| SNYDER CAPITAL MANAGEMENT L P | 1,222,547 | $39,843,000 | 2.07% |
| KESTREL INVESTMENT MANAGEMENT CORP | 441,250 | $14,380,000 | 1.78% |
| STONE RUN CAPITAL, LLC | 33,740 | $1,100,000 | 0.80% |
| HERMES INVESTMENT MANAGEMENT LTD | 728,123 | $23,730,000 | 0.75% |
| ANCHOR CAPITAL ADVISORS LLC | 1,119,060 | $36,470,000 | 0.73% |
| Netols Asset Management, Inc. | 137,267 | $4,473,000 | 0.72% |